Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Berberine on Primary Prevention of Cardiovascular Diseases and Diabetes in Metabolic Syndrome: a Randomized, Controlled Trial

NCT05105321 is registered in ClinicalTrials.gov with Tang Yida as lead sponsor.

NCT NCT05105321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05105321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Berberine on Primary Prevention of Cardiovascular Diseases and Diabetes in Metabolic Syndrome: a Randomized, Controlled Trial
Lead sponsor
Tang Yida
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 31, 2021
Completion date
December 31, 2028
Enrollment
5,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome